ALBEMARLE CORP ALB

Healthcare SIC 2821 - Plastic Materials, Synth Resins & Nonvulcan Elastomers NAICS Manufacturing › Chemical Manufacturing › Resin, Synthetic Rubber, and Artificial and Synthetic Fibers and Filaments Manufacturing › Resin and Synthetic Rubber Manufacturing › Plastics Material and Resin Manufacturing derived NYSE

Albemarle Corporation was incorporated in Virginia in 1993. Our principal executive offices are located at 4250 Congress Street, Suite 900, Charlotte, North Carolina 28209. Unless the context otherwise indicates, the terms "Albemarle," "we," "us," "our" or "the Company" mean Albemarle Corporation and its consolidated subsidiaries.

Albemarle is a world leader in transforming essential resources into critical ingredients for mobility, energy, connectivity, and health. Our purpose is to enable a more resilient world. We partner to pioneer new ways to move, power, connect, and protect. The end markets we serve include grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture and food, pharmaceuticals and medical devices. We believe that our world-class resources with reliable and consistent supply, our leading process chemistry, high-impact innovation, customer centricity and focus on people and planet will enable us to maintain a leading position in the industries in which we operate.

Last close 93.67 2026-10-23
Market cap $11.05B 2026-06-30 share count
52-week range 88.01 - 221.00

Valuation FY2025 figures against the last close

P/S2.1x
P/E—
P/FCF16.0x
EV/EBITDA43.3x
Dividend yield1.7%
Diluted EPS-5.76

Where the revenue comes from as reported in the latest 10-K

Revenue by geography

  • China
  • Other
  • United States
  • South Korea
  • Japan
Revenue by geography, 5 categories over 3 years. The same figures are in the table below. FY2025 China, FY2025: 2B (39.4%) 39% China Other, FY2025: 1.1B (20.9%) 21% Other United States, FY2025: 890.5M (17.3%) 17% United States South Korea, FY2025: 789.5M (15.4%) 15% South Korea Japan, FY2025: 359.6M (7.0%) 7% Japan FY2024 China, FY2024: 2B (36.5%) 36% Other, FY2024: 1B (18.8%) 19% United States, FY2024: 901.9M (16.8%) 17% South Korea, FY2024: 912.4M (17.0%) 17% Japan, FY2024: 589.3M (11.0%) 11% FY2023 China, FY2023: 2.9B (29.7%) 30% Other, FY2023: 1.3B (13.7%) 14% United States, FY2023: 930.8M (9.7%) 10% South Korea, FY2023: 3.1B (32.5%) 32% Japan, FY2023: 1.4B (14.5%) 15%
Region FY2025FY2024FY2023
China $2.03B $1.96B $2.85B
Other $1.08B $1.01B $1.31B
United States $890.5M $901.9M $930.8M
South Korea $789.5M $912.4M $3.13B
Japan $359.6M $589.3M $1.40B

As the company reported it, from the “Segment and Geographic Area Information - Net Sales by Geographic Area (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Regions are the filer's own and are not mapped onto a standard list — one company's “Americas” and another's “United States” are different areas, and making them look comparable would mean making at least one of them wrong. Slices under 1% are folded into “Other”.

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $5.14B$5.38B$9.62B$7.32B$3.33B$3.13B$3.59B$3.37B$3.07B$2.68B
Cost of revenue $4.47B$5.31B$8.43B$4.25B$2.33B$2.13B$2.33B$2.16B$1.97B$1.71B
Gross profit $668.7M$62.5M$1.19B$3.07B$998.0M$994.9M$1.26B$1.22B$1.11B$970.3M
R&D $51.4M$86.7M$85.7M$72.0M$54.0M$59.2M$58.3M$70.1M$84.3M$80.5M
SG&A $550.0M$618.0M$910.0M$524.1M$441.5M$429.8M$533.4M$446.1M$450.3M$353.8M
Operating income -$367.1M-$1.78B$251.9M$2.47B$798.4M$505.8M$666.1M$911.5M$571.7M$601.0M
Pre-tax income -$552.1M-$1.76B$246.7M$2.43B$133.6M$373.5M$563.0M$794.7M$446.8M$515.3M
Income tax $156.9M$87.1M$430.3M$390.6M$29.4M$54.4M$88.2M$144.8M$431.8M$96.3M
Net income -$510.6M-$1.18B$1.57B$2.69B$123.7M$375.8M$533.2M$693.6M$54.9M$643.7M
EPS, basic -5.76-11.2013.4122.971.073.535.036.400.495.73
EPS, diluted -5.76-11.2013.3622.841.063.525.026.340.495.68
Shares, diluted (wtd. avg.) 117.7M117.5M117.8M117.8M116.5M106.8M106.3M109.5M112.4M113.2M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $1.62B$1.19B$889.9M$1.50B$439.3M$746.7M$613.1M$555.3M$1.14B$2.27B
Receivables $593.5M$742.2M$1.21B$1.19B$556.9M$530.8M$612.7M$605.7M$534.3M$486.0M
Inventory $1.18B$1.50B$2.16B$2.08B$798.6M$750.2M$769.0M$700.5M$592.8M$450.3M
Total current assets $4.01B$3.84B$5.22B$5.19B$1.99B$2.21B$2.23B$2.00B$2.48B$3.31B
Property, plant and equipment ————$5.91B$5.35B$4.91B$3.02B$2.49B$2.36B
Goodwill $1.50B$1.58B$1.63B$1.62B$1.60B$1.67B$1.58B$1.57B$1.61B$1.54B
Other intangibles $214.2M$230.8M$261.9M$287.9M$308.9M$349.1M$354.6M$386.1M$421.5M$354.6M
Total assets $16.37B$16.61B$18.27B$15.46B$10.97B$10.45B$9.86B$7.58B$7.75B$8.16B
Accounts payable ———$1.53B$600.5M$483.2M$574.1M$522.5M$418.5M$281.9M
Short-term debt $74.1M$398.0M$625.8M$2.1M$389.9M$804.7M$187.3M$307.3M$422.0M$247.5M
Total current liabilities $1.80B$1.97B$3.56B$2.74B$1.87B$1.80B$1.41B$1.18B$1.20B$1.14B
Long-term debt $3.12B$3.12B$3.54B$3.21B$2.00B$2.77B$2.86B$1.40B$1.42B$2.12B
Retained earnings $4.61B$5.48B$6.99B$5.60B$3.10B$3.16B$2.94B$2.57B$2.04B$2.12B
Total equity $9.53B$9.96B$9.67B$8.19B$5.81B$4.47B$4.09B$3.76B$3.82B$3.94B

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $1.28B$687.9M$1.33B$1.91B$344.3M$798.9M$719.4M$546.2M$304.0M$735.5M
Depreciation and amortisation $658.7M$588.6M$429.9M$300.8M$254.0M$232.0M$213.5M$200.7M$196.9M$226.2M
Stock-based compensation $40.3M$32.1M$36.5M$30.5M$20.1M$22.8M$19.7M$15.2M$19.4M$17.0M
Capital expenditure $589.8M$1.68B$2.15B$1.26B$953.7M$850.5M$851.8M$700.0M$317.7M$196.7M
Investing cash flow -$146.0M-$1.58B-$2.56B-$1.42B-$666.6M-$863.6M-$1.66B-$303.7M-$357.8M$2.92B
Financing cash flow -$834.2M$1.24B$623.9M$611.9M$50.2M$177.3M$1.04B-$786.5M-$1.09B-$1.58B
Dividends paid $190.5M$188.5M$187.2M$184.4M$177.9M$161.8M$152.2M$144.6M$140.6M$135.4M
Buybacks —————$0$0$500.0M$250.0M$0

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0000915913-26-000060.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -5B 0 5B 10B Revenue, FY2016: 2.7B Gross profit, FY2016: 970.3M Net income, FY2016: 643.7M Revenue, FY2017: 3.1B Gross profit, FY2017: 1.1B Net income, FY2017: 54.9M Revenue, FY2018: 3.4B Gross profit, FY2018: 1.2B Net income, FY2018: 693.6M Revenue, FY2019: 3.6B Gross profit, FY2019: 1.3B Net income, FY2019: 533.2M Revenue, FY2020: 3.1B Gross profit, FY2020: 994.9M Net income, FY2020: 375.8M Revenue, FY2021: 3.3B Gross profit, FY2021: 998M Net income, FY2021: 123.7M Revenue, FY2022: 7.3B Gross profit, FY2022: 3.1B Net income, FY2022: 2.7B Revenue, FY2023: 9.6B Gross profit, FY2023: 1.2B Net income, FY2023: 1.6B Revenue, FY2024: 5.4B Gross profit, FY2024: 62.5M Net income, FY2024: -1.2B Revenue, FY2025: 5.1B Gross profit, FY2025: 668.7M Net income, FY2025: -510.6M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $2.68B $3.07B $3.37B $3.59B $3.13B $3.33B $7.32B $9.62B $5.38B $5.14B
Gross profit $970.3M $1.11B $1.22B $1.26B $994.9M $998.0M $3.07B $1.19B $62.5M $668.7M
Net income $643.7M $54.9M $693.6M $533.2M $375.8M $123.7M $2.69B $1.57B -$1.18B -$510.6M

Recent filings and events

  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Officer or director change Item 5.02
  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Officer or director change Item 5.02
  • Regulation FD disclosure Item 7.01
  • Officer or director change Item 5.02
  • Officer or director change Item 5.02
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Results announced Item 2.02
  • Officer or director change Item 5.02
  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2821

TickerCompanyMarket capP/ERevenue growth
DOW DOW INC. $23.50B — -7.0%
DD DuPont de Nemours, Inc. $18.44B — 1.9%
EMN EASTMAN CHEMICAL CO $7.43B 15.8x -6.7%
HXL HEXCEL CORP /DE/ $6.02B — -0.5%
AVNT AVIENT CORP $3.76B 46.1x 0.6%
ROG ROGERS CORP $2.23B — -2.3%
PCT PureCycle Technologies, Inc. $556.5M — —
ASIX AdvanSix Inc. $424.2M 8.7x 0.3%